TrialDrug design, development and therapy2015

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.

Sang-In Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.